>

CLAL BIOTECHNOLOGY Total Debt

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>CLA</div>
CLAL BIOTECHNOLOGY total debt fundamental analysis lookup allows you to check this and other indicators for CLAL BIOTECHNOLOGY or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools
Equity
Refresh

CLAL BIOTECHNOLOGY Total Debt Analysis

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Total Debt 
 = 
Bonds 
+  
Notes 
More About Total Debt | All Equity Analysis
CLAL BIOTECHNOLOGY Total Debt  =  
52.28 M
ValuationFinancialsBuy or Sell

About Total Debt

In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.Compare to competition
Based on latest financial disclosure CLAL BIOTECHNOLOGY has Total Debt of 52.28 M. This is 98.1% lower than that of the Healthcare sector, and 83.9% lower than that of Biotechnology industry, The Total Debt for all stocks is 99.02% higher than the company.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

CLAL BIOTECHNOLOGY Fundamentals

Current Sentiment - CBI

CLAL BIOTECHNOLOGY Investor Sentiment

Most of Macroaxis users are currently bullish on CLAL BIOTECHNOLOGY. What is your opinion about investing in CLAL BIOTECHNOLOGY? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

CLAL BIOTECHNOLOGY Pair Correlation

Equities Pair Trading Analysis

Continue to Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.